OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
56
Views
4
CrossRef citations to date
0
Altmetric
Original Research
Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) – non-interventional study
Christoph Losem1 Praxis für Hämatologie und Onkologie, NeussCorrespondence[email protected]
, Michael Koenigsmann2 Onkologisches Ambulanzzentrum, Marienstr, Hannover
& Christine Rudolph3 Hospira Germany, A Pfizer Company, München, Germany
Pages 1295-1305
|
Published online: 28 Feb 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.